![]() |
市场调查报告书
商品编码
1881338
全球製氧机市场:依类型、形式、技术、应用和地区划分 - 市场规模、行业趋势、机会分析和预测(2025-2033 年)Global Oxygen Generator Market: By Type, Form, Technology, Application, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025-2033 |
||||||
全球製氧机市场是一个规模庞大且快速成长的产业,预计收入将从 2024 年的 18.622 亿美元成长到 2033 年的 29.138 亿美元。这意味着在 2025 年至 2033 年的预测期内,复合年增长率 (CAGR) 为 5.1%。这一成长主要受医疗和工业领域对制氧机需求不断增长的驱动。
除了医疗和工业领域的需求外,全球医疗保健基础设施的扩张,包括对医疗设施和技术的大量投资,也支撑着市场的发展。此外,水产养殖业也已成为一个重要的贡献者,制氧机被用于维持鱼场和水生环境中的最佳氧气水平,从而提高生产力和永续性。这些多元化的因素共同凸显了全球製氧机市场的动态性和多面性,预计未来几年该市场将持续成长。
制氧机市场拥有众多主要竞争对手,包括阿特拉斯·科普柯 (Atlas Copco)、飞利浦伟康 (Philips Respironics) 和瑞思迈 (ResMed) 等行业领导者。这些公司凭藉着丰富的产品组合、技术创新和全球分销网络,奠定了坚实的基础。为了进一步巩固市场地位,这些公司正积极寻求整合,包括併购,以扩大自身能力、提高市场占有率并进入新的区隔市场。
除了传统医用製氧技术的进步外,与氧气技术相关的领域也不断涌现创新。一个值得关注的例子是捷途宗恆 G700 PHEV,该车型于 2025 年 10 月推出。这是一款配备外置制氧机的插电式混合动力电动车。这款车拥有令人印象深刻的 1400 公里续航里程、强劲的 892 马力发动机,以及极具竞争力的约 46,300 美元的售价。将氧气发生技术应用于汽车领域,标誌着跨产业创新趋势的兴起。
主要成长因素
推动医用氧气产生器市场成长的关键因素之一是高压氧疗法 (HBOT) 的快速普及。这种特殊疗法透过在高于大气压力的环境下输送高纯度氧气来促进康復和治疗各种疾病,从而对可靠的氧气输送系统产生了巨大的需求。预计仅在 2024 年,美国就将新增 150 家独立的高压氧治疗诊所,反映出该疗法的认可度和普及程度不断提高。高压氧治疗对氧气的需求尤其强劲。例如,到 2025 年,平均每次单舱高压氧疗程将消耗约 7,000 公升氧气,这凸显了可靠的现场製氧系统的重要性。
新兴成长机会
兽医保健产业是製氧机市场一个极具发展潜力的领域。随着兽医院和诊所的日益完善,专业现场製氧系统的应用也日益增加。这些系统在关键应用中发挥着至关重要的作用,例如在外科手术中提供麻醉,以及在小型动物重症监护室中维持生命维持。兽医护理的日益复杂化以及对高品质护理的日益重视,正在推动这一专业领域对可靠且高效的氧气供应解决方案的需求。
优化障碍
预计在预测期内,医用製氧机的高昂成本将对制氧机市场的成长构成重大挑战。这些设备对于可靠、持续的氧气供应至关重要,但通常需要大量的初始投资和维护成本。为确保安全高效的氧气供应,所需的先进技术、精密工程和高品质材料都推高了总成本,使得一些医疗机构和患者,尤其是在对成本较为敏感的地区,难以负担这些氧气发生器。这种财务障碍可能会限制产品的普及率,尤其是在医疗预算有限、成本效益至关重要的新兴市场。
The global oxygen generator market represents a substantial and rapidly expanding industry, with revenues projected to grow from US$ 1,862.2 million in 2024 to an impressive US$ 2,913.8 million by 2033. This growth corresponds to a compound annual growth rate (CAGR) of 5.1% over the forecast period spanning 2025 to 2033. The primary forces fueling this expansion stem from the increasing demand for oxygen generators across both medical and industrial applications.
In addition to healthcare and industrial demand, the market is also supported by expanding healthcare infrastructure worldwide, reflecting broader investments in medical facilities and technologies. Furthermore, the aquaculture industry is emerging as a noteworthy contributor, as oxygen generators are increasingly utilized to maintain optimal oxygen levels in fish farms and aquatic environments, enhancing productivity and sustainability. Together, these diverse factors underscore the dynamic and multifaceted nature of the global oxygen generator market, positioning it for sustained growth in the coming year.
The oxygen generator market features several key competitive players, including industry leaders such as Atlas Copco, Philips Respironics, and ResMed. These companies have established strong footholds through extensive product portfolios, technological innovation, and global distribution networks. To further solidify their market positions, these players are actively engaging in consolidation efforts, including mergers and acquisitions, which allow them to expand capabilities, increase market share, and enter new segments.
In addition to developments within traditional medical oxygen generation, the market is witnessing innovations in related sectors that intersect with oxygen technology. A notable example is the October 2025 introduction of the Jetour Zongheng G700 PHEV, a plug-in hybrid electric vehicle equipped with an external oxygen generator. This vehicle boasts an impressive driving range of 1,400 kilometers and a powerful 892-horsepower engine, all offered at a competitive price of approximately 46,300 USD. The integration of oxygen generation technology into automotive applications signals a broader trend of cross-industry innovation.
Core Growth Drivers
A significant factor driving the growth of the medical oxygen generator market is the rapid expansion of Hyperbaric Oxygen Therapy (HBOT). This specialized treatment, which involves delivering pure oxygen at higher-than-atmospheric pressures to promote healing and treat various medical conditions, has generated substantial demand for reliable oxygen supply systems. In 2024 alone, the United States saw the opening of 150 new standalone HBOT clinics, reflecting the therapy's growing acceptance and popularity. The oxygen requirements for HBOT are notably high; for example, an average monoplace HBOT session in 2025 consumes approximately 7,000 liters of oxygen, underscoring the critical need for dependable on-site oxygen generation.
Emerging Opportunity Trends
A promising area of growth in the oxygen generator market lies within the veterinary care sector. As veterinary hospitals and clinics become more advanced, there is a growing trend toward the adoption of on-site oxygen generation systems tailored specifically for animal healthcare. These systems play an essential role in critical applications such as delivering anesthesia during surgical procedures and providing life support in intensive care units for small animals. The increasing complexity of veterinary treatments and the rising emphasis on high-quality care are driving demand for reliable and efficient oxygen supply solutions within this specialized field.
Barriers to Optimization
The high cost associated with medical oxygen generators is anticipated to pose a significant challenge to the growth of the oxygen generator market during the forecast period. These devices, while essential for providing reliable and continuous oxygen supply, often involve substantial initial investment and maintenance expenses. The advanced technology, precision engineering, and quality materials required to ensure safe and efficient oxygen delivery contribute to the overall cost, making these generators less accessible for some healthcare providers and patients, particularly in cost-sensitive regions. This financial barrier can limit adoption rates, especially in emerging markets where healthcare budgets are constrained and cost-effectiveness is a critical consideration.
By Type, the small Pressure Swing Adsorption (PSA) oxygen generator segment is projected to capture the highest revenue share within the oxygen generator market. This segment's dominance is underpinned by its widespread adoption and proven reliability across diverse applications and industries. By 2024, over 650,000 PSA units will have been installed globally, demonstrating the technology's extensive reach and acceptance. The versatility and efficiency of small PSA oxygen generators make them particularly appealing for a range of settings, from healthcare facilities to industrial uses, where a consistent and cost-effective oxygen supply is essential.
By Form, the portable oxygen generators segment has secured the largest share in the global oxygen generator market, reflecting a strong alignment with patient needs for enhanced mobility and improved quality of life. This segment's prominence is driven by the increasing desire among individuals requiring oxygen therapy to maintain an active lifestyle without being tethered to bulky, stationary equipment.
By Application, the home-use oxygen segment holds the largest share in the global oxygen generator market. This dominance is primarily due to the rising number of patients worldwide who require long-term oxygen therapy. The shift towards home healthcare is driven by patient preference for comfort, cost-effectiveness, and the increasing availability of portable and user-friendly oxygen generation technologies.
By Type
By Form
By Technology
By Application
By Region
Geography Breakdown